Congratulations to Sichuan Neautus Traditional Chinese Medicine Co., Ltd.(2206.HK) on its Successful Listing

Congratulations to Sichuan Neautus Traditional Chinese Medicine Co., Ltd.(2206.HK) on its successful Listing on the Mainboard of HKSE on 11 November 2026.

Sichuan Neautus Traditional Chinese Medicine Co., Ltd. is a large-scale traditional Chinese medicine decoction-ready products provider in China. It serves a broad range of institutional and retail clients — including hospitals and medical institutions, medical trading companies, pharmacies, pharmaceutical companies, and more recently, individual consumers — with traditional herbal preparations, wellness products, and health management services. 

With regard to this listing application, AVISTA Group is honored to be engaged in providing valuation services on the expected credit loss assessment of the financial assets and the incremental borrowing rate assessment.

Congratulations again Sichuan Neautus Traditional Chinese Medicine Co., Ltd.(2206.HK) on its successful listing. The issue price of the shares is HKD 40.20 per share, and the amount of funds raised is HKD 262 million.

幻灯片1.JPG

Meet Our People

JOJO HU

JOJO HU

Senior Manager

VALUATION ADVISORY

jojo.hu@avaval.com

Date: 11 Nov 2026 | Tags: Business Valuation

News

About UsOur ServicesOur ExperienceNewsOur Sustainability StrategyResearch and InsightsCompany EventsCareersContact Us

© COPYRIGHT 2026 AVISTA GROUP, ALL RIGHTS RESERVED

沪ICP备17054339号Privacy & Disclaimer

AVISTA is collaborating with Anderson Global in China